1. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-α levels in drug-naive individuals with first-episode schizophrenia
- Author
-
Xiaofeng Zhao, Wenli Zhu, Yangying Bu, Junwei Li, Yihui Hao, and Yuxiao Bi
- Subjects
Interleukin-2 ,Interleukin-8 ,Interleukin-10 ,Tumor necrosis factor-alpha ,Schizophrenia ,Psychiatry ,RC435-571 - Abstract
Abstract Background Schizophrenia is a complex neuropsychiatric disorder. Growing evidence indicates that the activation of the inflammatory response system with interleukin (IL)-2, IL-4, IL-8, IL-10, and tumor necrosis factor-alpha (TNF-α) plays an important role in the pathogenesis of schizophrenia,. However, clinical data on cytokine levels in patients with schizophrenia treated with antipsychotics are inconsistent or inconclusive. In this study, we have examined inflammatory factors’ alterations and their relationship to changes in clinical symptoms before and after olanzapine treatment of drug-naive patients with first-episode schizophrenia. Methods We recruited 142 hospitalized patients with first-episode schizophrenia as a study group; blood samples were collected, and the patients were assessed for clinical symptoms at baseline and after 6 weeks of olanzapine treatment. One hundred individuals with no history of mental illness were also recruited as healthy controls. Blood samples were collected, and the serum levels of IL-2, IL-4, IL-8, IL-10, and TNF-α were determined using an enzyme cycling assay. The severity of clinical symptoms was assessed according to the Positive and Negative Syndrome Scale (PANSS). Results Individuals with schizophrenia had lower IL-8 levels and higher IL-10 levels than healthy controls (P
- Published
- 2024
- Full Text
- View/download PDF